Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pagaya Technologies Ltd.PGY · Entity 2362 | Director | November 14, 2024 | November 18, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pagaya Technologies Ltd.
Report date November 14, 2024 · Filed November 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary ShareSEC Table I · non-derivative | Direct | 9,487 |
Ending reported balance
After 2024-11-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-11-14 · Grant · Acquired 4,743 · Balance 11,858 Row 2 · 2024-11-15 · Sale · Disposed 2,371 · Balance 9,487 F1: Shares were sold in large part to cover taxes incurred upon the vesting of restricted stock units pursuant to a Rule 10b5-1 plan dated March 21, 2024. F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $8.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-11-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-11-14 · Exercise / conversion · Acquired 4,743 · Balance 0 F3: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were sold in large part to cover taxes incurred upon the vesting of restricted stock units pursuant to a Rule 10b5-1 plan dated March 21, 2024.
F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $8.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Sharecare, Inc.
Report date October 22, 2024 · Filed October 25, 2024
Section 16 reporting ended · disclosed 2024-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-10-22 transaction · row 1
1 source rowRow 1 · 2024-10-22 · Disposition to issuer · Disposed 43,124 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-10-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-22 · Disposition to issuer · Disposed 76,667 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2024 Filed Nov 18, 2024 22:01 UTC | Pagaya Technologies Ltd. PGY · Entity 2362 | SaleClass A Ordinary Share | 2,371 | $8.92 | $21,160.70 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · nonDerivative · entry 2 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,487 F1 · kind: Shares were sold in large part to cover taxes incurred upon the vesting of restricted stock units pursuant to a Rule 10b5-1 plan dated March 21, 2024. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $8.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 22:01 UTC | Pagaya Technologies Ltd. PGY · Entity 2362 | Exercise / conversionRestricted Stock Unit · Derivative | 4,743 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · derivative · entry 3 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Share · 4,743 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments. F3 · derivative.expiration_date: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 22:01 UTC | Pagaya Technologies Ltd. PGY · Entity 2362 | GrantClass A Ordinary Share | 4,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,858 Read SEC document |
| October 22, 2024 Filed Oct 25, 2024 06:08 UTC | Sharecare, Inc. SHCR · Entity 86549 | Disposition to issuerRestricted Stock Units · Derivative | 76,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043733 · wk-form4_1729850930.xml · derivative · entry 2 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,667 shares Expires not disclosed F2 · derivative.exercise_price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration. F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit of Reporting Person ("Company RSU Award") was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product of multiplying (A) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Effective Time by (B) the Merger Consideration. Read SEC document |
| October 22, 2024 Filed Oct 25, 2024 06:08 UTC | Sharecare, Inc. SHCR · Entity 86549 | Disposition to issuerCommon Stock | 43,124 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-043733 · wk-form4_1729850930.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated as of June 21, 2024 (the "Merger Agreement"), by and among Sharecare, Inc. ("Sharecare"), Impact Acquiror Inc., a Delaware corporation ("Parent") and Impact Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Sharecare common stock, par value $0.0001 ("Company Common Stock"), reported in this row was converted into the right to receive a cash payment (without interest and subject to applicable taxes) equal to the per share merger consideration of $1.43 (the "Merger Consideration"). As a result of the Merger, Reporting Person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:12 UTC | Pagaya Technologies Ltd. PGY · Entity 2362 | SaleClass A Ordinary Share | 2,371 | $12.15 | $28,810.02 |
DisclosureSEC source: 0001883085-24-000101 · wk-form4_1724098345.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares were sold in large part to cover taxes incurred upon the vesting of restricted stock units pursuant to a Rule 10b5-1 plan dated March 21, 2024. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.59 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:07 UTC | Pagaya Technologies Ltd. PGY · Entity 2362 | SaleClass A Ordinary Share | 4,743 | $12.04 | $57,097.66 |
DisclosureSEC source: 0001628280-24-029364 · wk-form4_1719004011.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $11.86 to $12.26 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:31 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionRestricted Stock Units · Derivative | 43,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-028975 · wk-form4_1718760692.xml · derivative · entry 3 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,667 Underlying: Common Stock · 43,124 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. F3 · derivative.exercise_date: Represents annual equity grants to directors. 43,124 of the RSUs vest and are settled as of the grant date. The remaining 76,667 RSUs will vest on the earlier of (i) the 2025 annual meeting of the Company's stockholders and (ii) June 14, 2025, subject to Reporting Person's continued service as a director of the Company. F3 · derivative.expiration_date: Represents annual equity grants to directors. 43,124 of the RSUs vest and are settled as of the grant date. The remaining 76,667 RSUs will vest on the earlier of (i) the 2025 annual meeting of the Company's stockholders and (ii) June 14, 2025, subject to Reporting Person's continued service as a director of the Company. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:31 UTC | Sharecare, Inc. SHCR · Entity 86549 | GrantRestricted Stock Units · Derivative | 119,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-028975 · wk-form4_1718760692.xml · derivative · entry 2 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,791 Underlying: Common Stock · 119,791 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date. F3 · derivative.exercise_date: Represents annual equity grants to directors. 43,124 of the RSUs vest and are settled as of the grant date. The remaining 76,667 RSUs will vest on the earlier of (i) the 2025 annual meeting of the Company's stockholders and (ii) June 14, 2025, subject to Reporting Person's continued service as a director of the Company. F3 · derivative.expiration_date: Represents annual equity grants to directors. 43,124 of the RSUs vest and are settled as of the grant date. The remaining 76,667 RSUs will vest on the earlier of (i) the 2025 annual meeting of the Company's stockholders and (ii) June 14, 2025, subject to Reporting Person's continued service as a director of the Company. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:31 UTC | Sharecare, Inc. SHCR · Entity 86549 | Exercise / conversionCommon Stock | 43,124 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-028975 · wk-form4_1718760692.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Filed to report vesting and settlement of Restricted Stock Units ("RSUs"). RSUs converted into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.